Tom Parker

1.5k total citations
27 papers, 1.1k citations indexed

About

Tom Parker is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Tom Parker has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 6 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Tom Parker's work include Dialysis and Renal Disease Management (14 papers), Central Venous Catheters and Hemodialysis (4 papers) and Acute Kidney Injury Research (4 papers). Tom Parker is often cited by papers focused on Dialysis and Renal Disease Management (14 papers), Central Venous Catheters and Hemodialysis (4 papers) and Acute Kidney Injury Research (4 papers). Tom Parker collaborates with scholars based in United States, Italy and Canada. Tom Parker's co-authors include Alan R. Hull, Nancy L. Lew, Edmund G. Lowrie, Raymond M. Hakim, Derek Blankenship, James P. Knöchel, Alan Menter, Jon D. Blachley, Rebecca L. Wingard and Robert A. Parker and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Tom Parker

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Parker United States 16 675 223 212 134 130 27 1.1k
C. Loschiavo Italy 16 523 0.8× 244 1.1× 156 0.7× 356 2.7× 73 0.6× 40 960
Marianne Haag–Weber Germany 19 677 1.0× 204 0.9× 237 1.1× 138 1.0× 89 0.7× 55 1.3k
J. Bömmer Germany 17 625 0.9× 166 0.7× 211 1.0× 206 1.5× 78 0.6× 60 1.1k
Ralph J. Caruana United States 16 302 0.4× 92 0.4× 150 0.7× 175 1.3× 112 0.9× 40 733
Alaa Sabry Egypt 20 459 0.7× 70 0.3× 177 0.8× 161 1.2× 119 0.9× 103 1.3k
W Fassbinder Germany 17 341 0.5× 52 0.2× 210 1.0× 131 1.0× 85 0.7× 72 1.0k
Misaki Moriishi Japan 19 731 1.1× 151 0.7× 479 2.3× 284 2.1× 25 0.2× 74 945
Silvana Savoldi Italy 16 410 0.6× 79 0.4× 229 1.1× 292 2.2× 123 0.9× 44 1.1k
Marc Bauwens France 15 343 0.5× 58 0.3× 132 0.6× 43 0.3× 329 2.5× 48 906
A Giangrande Italy 13 778 1.2× 173 0.8× 298 1.4× 200 1.5× 39 0.3× 46 1.1k

Countries citing papers authored by Tom Parker

Since Specialization
Citations

This map shows the geographic impact of Tom Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Parker more than expected).

Fields of papers citing papers by Tom Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Parker. The network helps show where Tom Parker may publish in the future.

Co-authorship network of co-authors of Tom Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Parker. A scholar is included among the top collaborators of Tom Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Parker. Tom Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Adrian Y., Genyan Liu, Olivier Elemento, et al.. (2014). Molecular Diagnosis of Autosomal Dominant Polycystic Kidney Disease Using Next-Generation Sequencing. Journal of Molecular Diagnostics. 16(2). 216–228. 51 indexed citations
2.
Liu, Genyan, Adrian Y. Tan, Jon D. Blumenfeld, et al.. (2014). Development and validation of a whole genome amplification long-range PCR sequencing method for ADPKD genotyping of low-level DNA samples. Gene. 550(1). 131–135. 5 indexed citations
3.
Weiner, Daniel E., Steven M. Brunelli, Brigitte Schiller, et al.. (2014). Improving Clinical Outcomes Among Hemodialysis Patients: A Proposal for a “Volume First” Approach From the Chief Medical Officers of US Dialysis Providers. American Journal of Kidney Diseases. 64(5). 685–695. 105 indexed citations
4.
Parker, Tom. (2012). The Economic Burden of Geriatric ESRD. Seminars in Dialysis. 25(6). 664–667. 1 indexed citations
5.
Blumenfeld, Jon D., et al.. (2012). A Novel Long-Range PCR Sequencing Method for Genetic Analysis of the Entire PKD1 Gene. Journal of Molecular Diagnostics. 14(4). 305–313. 37 indexed citations
6.
Spiegel, Brennan, Roger Bolus, Amar A. Desai, et al.. (2010). Dialysis Practices That Distinguish Top- Versus Bottom-Performing Facilities by Hemoglobin Outcomes. American Journal of Kidney Diseases. 56(1). 86–94. 10 indexed citations
7.
Barri, Yousri M., Tom Parker, Yahya Daoud, & Richard J. Glassock. (2010). Definition of Chronic Kidney Disease After Uninephrectomy in Living Donors: What Are the Implications?. Transplantation. 90(5). 575–580. 33 indexed citations
8.
Spiegel, Brennan, Roger Bolus, Amar A. Desai, et al.. (2010). Dialysis Practices That Distinguish Facilities with Below- versus Above-Expected Mortality. Clinical Journal of the American Society of Nephrology. 5(11). 2024–2033. 18 indexed citations
9.
Parker, Tom & Theodore I. Steinman. (2010). We Can Do Better—ESRD: State of the Art and Challenges for the Future. Dialysis & Transplantation. 39(1). 14–15.
10.
Quinn, Kieran L., et al.. (2008). Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. American Journal of Physiology-Heart and Circulatory Physiology. 295(5). H1817–H1824. 69 indexed citations
11.
Winchester, James F., Jeffrey Silberzweig, Claudio Ronco, et al.. (2004). Sorbents in Acute Renal Failure and End-Stage Renal Disease: Middle Molecule and Cytokine Removal. Blood Purification. 22(1). 73–77. 30 indexed citations
12.
Parker, Tom. (2000). Technical Advances in Hemodialysis Therapy. Seminars in Dialysis. 13(6). 372–377. 7 indexed citations
13.
Parker, Tom, et al.. (1996). Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney International. 49(2). 551–556. 132 indexed citations
14.
Parker, Tom. (1994). Role of Dialysis Dose on Morbidity and Mortality in Maintenance Hernodialysis Patients. American Journal of Kidney Diseases. 24(6). 981–989. 10 indexed citations
15.
Kopple, Joel D., Raymond M. Hakim, Philip J. Held, et al.. (1994). Recommendations for Reducing the High Morbidity and Mortality of United States Maintenance Dialysis Patients. American Journal of Kidney Diseases. 24(6). 968–973. 19 indexed citations
16.
Parker, Tom, et al.. (1994). Survival of Hemodialysis Patients in the United States Is Improved With a Greater Quantity of Dialysis. American Journal of Kidney Diseases. 23(5). 670–680. 198 indexed citations
17.
Hull, Alan R. & Tom Parker. (1990). Proceedings From the Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, TX, September 15 to 17, 1989. American Journal of Kidney Diseases. 15(5). 375–383. 86 indexed citations
18.
Parker, Tom, et al.. (1989). Evaluation of a New Disinfectant for Dialyzer Reuse. American Journal of Kidney Diseases. 14(2). 110–118. 10 indexed citations
19.
Blachley, Jon D., Derek Blankenship, Alan Menter, Tom Parker, & James P. Knöchel. (1985). Uremic Pruritus: Skin Divalent Ion Content and Response to Ultraviolet Phototherapy. American Journal of Kidney Diseases. 5(5). 237–241. 114 indexed citations
20.
Davis, Glenn R., Joseph E. Zerwekh, Tom Parker, et al.. (1983). Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency. Gastroenterology. 85(4). 908–916. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Loschiavo Breakdown of academic impact, for papers by Marianne Haag–Weber Breakdown of academic impact, for papers by J. Bömmer Breakdown of academic impact, for papers by Ralph J. Caruana Breakdown of academic impact, for papers by Alaa Sabry Breakdown of academic impact, for papers by W Fassbinder Breakdown of academic impact, for papers by Misaki Moriishi Breakdown of academic impact, for papers by Silvana Savoldi Breakdown of academic impact, for papers by Marc Bauwens Breakdown of academic impact, for papers by A Giangrande
Rankless by CCL
2026